Search results
Results from the WOW.Com Content Network
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland.Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.
Alcon offices in Johns Creek, Georgia. Alcon Inc. (German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
In June 2021, Morphosys announced its acquisition of clinical stage biotechnology company Constellation Pharma for US$1.7 billion. [20] In February 2024, Novartis agreed to acquire Morphosys for €2.7 billion. [4] In June 2024, Morphosys announced its intention to delist from the Frankfurt Stock Exchange and merge into Novartis.
Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline. [2]
(Reuters) -The U.S. Food and Drug Administration has approved the use of Novartis' drug to reduce excess protein in the urine of patients with a type of kidney disease, the health regulator's ...
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. [4] Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz.
Novartis CEO Vas Narasimhan has been vocal about the pressure the drug industry is facing both in the U.S. and in Europe, but he argues the Inflation Reduction Act and Europe's proposed patent ...